Abstract
Fecal incontinence (FI) is a frequently occcurring, distressing condition that has a devastating impact on the lives of patients. However, patients are typically embarrassed and reluctant to acknowledge this disability, so they do not seek a cure and remain socially isolated. The exact incidence of FI is not known, because of the reluctance of patients to seek help from their physicians. Most epidemiological studies suggest a prevalence of as high as 2% of the general population; however, when patient interviews ask specific questions about FI, the rate is usually significantly higher. Women seem to be at higher risk of FI, mostly because of obstetric damage to anal sphincters; however, during the last decade there has been increasing interest in types of FI with nontraumatic causes, as these have been shown to occur in significant numbers. Older subjects are at a very high risk of FI, especially those that present with disabilities or are institutionalized. Young patients are also often affected. This results in a significant economic impact for society because of the direct and indirect costs, and also for intangible reasons. Since FI can be the result of various pathophysiological conditions, and a variety of risk factors can cause a wide range of ways in which patients develop the inability to control the passage of feces, an accurate diagnostic work-up of each patient is fundamental.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Bharucha AE (2006) Update of tests of colon and rectal structure and function. J Clin Gastroenterol 40:96–103
Bharucha AE, Zinsmeister AR, Locke GR et al (2005) Prevalence and burden of fecal incontinence: A population based study in women. Gastroenterology 129:42–49
Glasgow SC, Lowry AC (2012) Long-term outcomes of anal sphincter repair for fecal incontinence: a systematic review. Dis Colon Rectum 55:482–490
Maeda Y, Laurberg S, Norton C (2013) Perianal injectable bulking agents as treatment for faecal incontinence in adults. Cochrane Database Syst Rev 282:CD007959
Maeda Y, O’Connell PR, Matzel KE, Laurberg S (2012) Sacral nerve stimulation for fecal incontinence: at a crossroad and future challenges. Dis Colon Rectum 55:621–624
Norton C, Cody JD (2012) Biofeedback and/or sphincter exercises for the treatment of faecal incontinence in adults. Cochrane Database Syst Rev 11;7:CD002111
Norton C, Whitehead WE, Bliss DZ et al (2010) Management of fecal incontinence in adults. Neurourol Urodyn 29:199–206
Rao SS (2010) Advances in diagnostic assessment of fecal incontinence and dyssynergic defecation. Clin Gastroenterol Hepatol 8:910–919
Rao SS, Ozturk R, Stessman M (2004) Investigation of the pathophysiology of fecal seepage. Am J Gastroenterol 99:2204–2209
Ratto C, Doglietto GB (eds) (2007) Fecal incontinence: diagnosis and treatment. Springer-Verlag, Milan
Ratto C, Litta F, Parello A et al (2012) Sacral nerve stimulation in faecal incontinence associated with an anal sphincter lesion: a systematic review. Colorectal Dis 14:e297–304
Ratto C, Parello A, Donisi L et al (2011) Novel bulking agent for faecal incontinence. Br J Surg 98:1644–1652
Schwandner O (2012) Significance of conservative treatment for faecal incontinence. Zentralbl Chir 137:323–327
Terra MP, Stoker J (2006) The current role of imaging techniques in faecal incontinence. Eur Radiol16:1727–1736
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Italia
About this chapter
Cite this chapter
Ratto, C., Parello, A., Donisi, L., Litta, F., De Simone, V., Zaccone, G. (2014). Fecal Incontinence. In: Gaspari, A.L., Sileri, P. (eds) Pelvic Floor Disorders: Surgical Approach. Updates in Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-5441-7_8
Download citation
DOI: https://doi.org/10.1007/978-88-470-5441-7_8
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5440-0
Online ISBN: 978-88-470-5441-7
eBook Packages: MedicineMedicine (R0)